This article explores the discrepancy between Wall Street analyst recommendations and the Zacks Rank for Tenet Healthcare (THC). It delves into the potential bias in analyst ratings and highlights the importance of considering a more reliable indicator like the Zacks Rank, which is driven by earnings estimate revisions.